H. Lundbeck a déclaré jeudi que l'Agence européenne des médicaments a autorisé l'utilisation élargie de son médicament contre ...
Le médicament Rxulti de la société pharmaceutique danoise Lundbeck a été autorisé dans l'UE pour le traitement de la ...
Dravet syndrome and other developmental epileptic encephalopathies are rare but devastating conditions that cause a host of symptoms in children, including seizures, intellectual disability ...
GlobalData on MSN8d
Bloom Science’s obesity therapy sustains weight loss after final dosingThe live biotherapeutic elicited a 2.3% drop in weight loss in patients, which was maintained for weeks after dosing had ...
Dravet syndrome and other developmental epileptic encephalopathies are rare but devastating conditions that cause a host of symptoms in children, including seizures, intellectual disability ...
The Independent Data Monitoring Committee overseeing the interim analysis of Study 1 of the Essential3 program has provided Praxis with the ...
Irish vet, Patricia Reilly, has joined President of the European Commission, Ursula von der Leyen's cabinet as agriculture ...
While Australian researchers are paving the way in epilepsy care, findings show the significant burden on carers and parents with children living with severe epilepsies. Professor Ingrid Scheffer AO, ...
Detailed price information for Praxis Precision Medicines Inc (PRAX-Q) from The Globe and Mail including charting and trades.
Praxis Precision Medicines, Inc.’s PRAX share price has dipped by 40.64%, which has investors questioning if this is right ...
US-based Praxis Precision has decided not to halt its Phase III trial examining its essential tremor (ET) therapy after an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback